Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:36 AM
Ignite Modification Date:
2025-12-25 @ 4:36 AM
NCT ID:
NCT04404218
Eligibility Criteria:
Inclusion Criteria:
* Adults over 40 years of age; and
* Mild to moderate symptoms including fever, dry cough, and tiredness; and
* Tested positive for SARS-Cov-2, via virological diagnosis (PCR), in the last 7 days; and
* Not hospitalized at the time of randomization, with no limitations on activities; and
* Willingness to complete questionnaires and records associated with the study.
Exclusion Criteria:
* Hospitalized patients at the time of enrollment; or
* Known allergy to study medication or its non-medicinal ingredients; or
* Currently taking açai extract or juice; or
* Chronic severe renal impairment (creatinine clearance \<30 mL/min or on renal replacement therapy); or
* Pregnant or breastfeeding patients; or
* Women who are planning to become pregnant during the study; or
* End-stage cancer or patients in whom imminent demise is anticipated and there is no commitment to active ongoing intervention; or
* Unable to provide informed consent; or
* Patients taking antiplatelet/blood-thinning medication; or
* Patients with unstable metabolic disease/chronic diseases/ diseases with any comorbidities and/or any serious medical condition or abnormality of clinical laboratory tests that precludes the patient's safe participation in and completion of the study or puts them in a greater risk of developing severe symptoms (e.g. Individuals with an acute infectious disease, immune-compromised, self-reported confirmation of HIV, other lung diseases such as asthma, emphysema, neurological conditions); or
* Patients who participated in other clinical research studies 30 days prior to screening; or
* Patients who are participating in another clinical trial at the same time.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Study:
NCT04404218
Study Brief:
Protocol Section:
NCT04404218